Granules India Limited — Important, 03-12-2024: General Updates

The US FDA has classified its recent inspection of Granules India's Gagillapur facility as "Official Action Indicated" (OAI), having issued six observations. Granules has addressed all the observations and is undergoing a thorough evaluation of the facility with the help of external experts to drive improvements. The company is optimistic about collaborating with the FDA to ensure compliance and approval in the near future. This proactive response aims to enhance operational capabilities and uphold quality standards, which could positively influence the company’s reputation and operational efficiency moving forward.